Where both eyes of a patient qualified for inclusion, only the one with worse field loss was used for analysis. The difference in mean age at presentation with early (stage 1) and end stage (stages 4 and 5) field loss was calculated and further age analysis performed for subgroups at different levels of untreated intraocular pressure at diagnosis -namely, 21-25 mm Hg, 26-30 mm Hg, over 30 mm Hg, etc. The estimated rate offield loss in untreated disease was then compared with the average rate of loss during treatment in the Glasgow trial of early trabeculectomy.8 Separate data were available for first year of medical therapy, conventional sequence of medical therapy followed by trabeculectomy where necessary, and after early or delayed trabeculectomy. The rate of The rate ofvisualfield loss in untreatedprimary open angleglaucoma A similar examination ofTable 3 shows the 5 9 year interval for all eyes >20 mm Hg to be significantly different from the 2-9 years for eyes >30 mm Hg (p=0 046) but the 5 9 year and 3-6 year intervals (0 317<p<01) and the 3-6 year and 2-9 year intervals (p>050) were not shown to be significantly different. There is, however, enough evidence to confirm that the trend to a shorter interval for disease progression with higher intraocular pressure is reliable. Table 4 is constructed to show the comparative rates of progression for treated and untreated glaucoma. The 3 '6 year figure for untreated disease from The study is based on patients whose diagnosis is confirmed after normal hospital referral and, although it includes patients screened for glaucoma when attending their optometrist or an ophthalmology clinic for reasons other than glaucoma, it is not based on comprehensive population screening. We are, however, merely attempting to identify the rate of field loss after the earliest field defects have appeared and need take no account of the period of ocular hypertension which precedes visual field defects. There have been several studies in which the interval before appearance of field defects in ocular hypertension has Whatever the approximation inherent in this method of investigation, the untreated disease seems to run a much shorter course than when modified by treatment (see Table  4 
